Clinical trials
Transplant Recipient clinical trials
Below are recruiting transplant recipient clinical trials, each written for real people, not researchers. We’re tracking 170 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05041140Recruiting
Xenon MRI test for lung problems after stem cell transplant
This study uses a special MRI test with xenon gas to look at lung function in adults who had a stem cell transplant and now have breathing-related complications. It may help doctors measure lung impairment more clearly and track changes over time.
Houston, TexasAges 18 years+ - NCT02129543Recruiting
Study immune recovery after stem cell or T-cell treatment
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
Miami, FloridaAges 18–75 - NCT01999361Recruiting
Prevent new immune reaction after islet transplant failure
This study looks at ways to prevent the body from developing a new harmful immune reaction after an islet transplant no longer works. It may help people who have already lost a transplanted islet graft from getting harder-to-treat immune responses later.
Miami, FloridaAges 18–70 - NCT02000687Recruiting
Long-term follow-up after islet transplant graft failure
This study follows people over the long term after their islet transplant fully stops working. It aims to learn what happens after complete graft loss and monitor health outcomes over time.
Miami, FloridaAges 18–75 - NCT06169592Recruiting
Bleeding and Clotting Risks After Living Donor Liver Transplant
This study is for people with severe liver cirrhosis who are getting a liver transplant from a living donor. It looks at the risk of bleeding or clotting problems after the transplant, to help doctors better manage these risks.
TashkentAges 18–70 - NCT07532382Recruiting
Personalized Stories to Help Young Kidney Transplant Recipients
This study uses personalized storytelling to help children aged 5–12 who have received a kidney transplant. Researchers believe that hearing stories from other transplant recipients might help children understand their condition better and cope with their new life after transplant.
Paris, Île-de-France RegionAges 5–12 - NCT07349498Recruiting
Heart health after stem cell transplant
This study follows patients who have had a stem cell transplant to see how their heart and blood vessels are doing over time. It helps doctors learn about long-term heart risks after transplant.
Beijing, Beijing MunicipalityAges Any age - NCT07333495Recruiting
Using MRI to check kidney transplant health
This study tests if a special MRI (without dye) can accurately measure how well a transplanted kidney is working. It is for people who have received a kidney transplant or a combined kidney-pancreas transplant, and for living donors.
Shiyan, HubeiAges 18 years+ - NCT03802695RecruitingPhase 1
Orca-Q pill to help during stem cell transplant
This Phase 1 trial studies Orca-Q to see if it is safe and works when added around the time of an allogeneic (donor) stem cell transplant for certain blood cancers. If you qualify, the study may offer a new option for managing the transplant immune response.
Duarte, CaliforniaAges 12–78 - NCT06798909RecruitingPhase 3
CMV prevention in kidney transplant patients
This trial tests two ways to prevent CMV in kidney transplant patients who are at high risk. It compares giving antiviral medicine preemptively (based on regular blood tests) versus giving it as prophylaxis (starting right after transplant). The goal is to see which approach prevents CMV infection better.
San Francisco, CaliforniaAges 18 years+ - NCT06431347Recruiting
Study on social factors in transplant care
This study looks at how social and financial challenges affect people getting a transplant or cell therapy at MD Anderson. Researchers want to talk to patients and their caregivers to better understand these challenges and improve care.
Houston, TexasAges 18 years+ - NCT06659952Recruiting
HIV+ donor hearts for HIV+ recipients
This trial tests whether hearts from donors who had HIV can be safely transplanted into people with HIV who need a heart transplant. It may offer a new option for those on the waiting list.
Dallas, TexasAges 18 years+ - NCT02007356RecruitingPhase 2
Donor immune cell infusions for viral infections after stem cell transplant
This trial studies whether directly infusing donor-made immune cells (virus-fighting T-cells) is safe and feasible in people who still have viral infections after a stem cell transplant. It may help your body control infections from adenovirus, CMV, or EBV when standard antiviral treatments aren’t working.
BaselAges 18–65 - NCT01629017Recruiting
Long-term follow-up after a stem cell transplant
This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.
Stanford, CaliforniaAges Up to 18 years - NCT06399302Recruiting
Improving outcomes for lung transplant patients
This study looks at ways to improve outcomes for people who are waiting for or have recently received a lung transplant. It aims to find better management strategies for both donors and recipients.
Los Angeles, CaliforniaAges 18 years+ - NCT05159466Recruiting
Transplant from HIV-positive donors to HIV-positive recipients
This trial studies whether it’s safe and effective for HIV-positive people to receive organ transplants from HIV-positive donors. It focuses on matching HIV treatment before and after transplant and checking for major complications.
Metairie, LouisianaAges 18 years+ - NCT07503834RecruitingPhase 1/Phase 2
Anakinra to prevent blood clots in kidney transplant patients
This trial tests whether a medicine called anakinra, which reduces inflammation, can prevent blood clots forming in the kidney after a transplant. It may help improve the chances of the new kidney working well.
NantesAges 18 years+ - NCT05739825Recruiting
Fecal transplant to change gut bacteria in C. difficile infection
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
RomaAges 18–90 - NCT07685353Recruiting
Genes and graft fat after liver transplant study
This study looks at how genetic differences between liver donors and recipients affect fat buildup in the new liver after transplantation. It may help doctors understand why some transplanted livers develop steatosis (fatty liver) after the surgery.
New DelhiAges 18 years+ - NCT05653232Recruiting
Preventing hepatitis C in kidney transplant recipients using antiviral pills
This study tests antiviral medicine given around the time of a kidney transplant to prevent hepatitis C infection when the donor has hepatitis C. It may help uninfected recipients stay hepatitis C–free after receiving the kidney.
La Jolla, CaliforniaAges 18 years+ - NCT07715500Recruiting
MRI of Bile Ducts in Living Liver Donors
This study uses an MRI scan to look at the bile ducts in healthy people who want to donate part of their liver. The goal is to see if the scan can help predict and prevent bile duct problems for the person receiving the liver.
New DelhiAges 18–55 - NCT04393181Recruiting
Study how donor heart function affects transplant outcomes
This study looks at how well donor hearts work and how that affects outcomes after heart transplantation. It may help transplant teams choose and use donor hearts more effectively.
Gothenburg, Västra Götaland CountyAges 18 years+ - NCT06210555Recruiting
MRI Study of Kidney Donors, Recipients, and Healthy People
This study uses advanced MRI scans to look at kidney health in living donors, transplant recipients, and healthy people. It aims to find links between MRI results and kidney function, fibrosis (scarring), and aging.
Aarhus, Central JutlandAges 18–80 - NCT06784440Recruiting
Finding noninvasive markers of graft injury after heart transplant
This study looks for noninvasive markers (like blood or urine tests) that can show if a heart transplant is being injured. It aims to make monitoring safer and easier for children and adults with congenital heart disease who have had a transplant.
BolognaAges Up to 44 years
Hear when a new Transplant Recipient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplant recipient?
- Yes. Clin2 currently lists 170 recruiting transplant recipient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplant recipient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplant recipient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.